As Russia Attracts MNCs, India's J.B.Chemicals Rumored To Put Star Brand Doktor Mom On The Block
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - The $ 160 million J. B. Chemicals & Pharmaceuticals Ltd. would have passed as any other average-sized Indian pharmaceutical company had it not owned Doktor Mom - the leading cough and cold OTC brand selling in Russia. The buzz on the deal street has brought the company to center stage as the Indian owners of the famous medication are said to have put the product up for sale
You may also be interested in...
Nycomed Expects More Dealmaking in Russia; Prepares Daxas Rollout In Turkey
Swiss drug maker Nycomed Pharma AS aims to increase revenues from emerging markets by 150% by 2015. The Zurich-based private equity-owned company has seen double-digit growth in Russia and Latin American markets in the past year, and now it is preparing for more deal-making from Moscow and a major product launch in Turkey to accelerate the growth
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).